Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Simon Joost

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6661-541X; OpenAlex author ID A5065866201. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Systematic Comparison of Pancreatic Ductal Adenocarcinoma Models Identifies a Conserved Highly Plastic Basal Cell State. Co-author DOI 10.1158/0008-5472.can-22-1742↗
  2. GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-10-4621↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dana Pe'er · 1 shared paper, 2022 · strength 0.13
  2. Matilda Holm · 1 shared paper, 2022 · strength 0.13
  3. Olivera Grbovic-Huezo · 1 shared paper, 2022 · strength 0.13
  4. Kenneth L Pitter · 1 shared paper, 2022 · strength 0.13
  5. Tuomas Tammela · 1 shared paper, 2022 · strength 0.13
  6. Anupriya Singhal · 1 shared paper, 2022 · strength 0.13
  7. Christine A. Iacobuzio–Donahue · 1 shared paper, 2022 · strength 0.13
  8. Maite G. Fernández‐Barrena · 1 shared paper, 2012 · strength 0.03
  9. Matthias Lauth · 1 shared paper, 2012 · strength 0.03
  10. Robert R. McWilliams · 1 shared paper, 2012 · strength 0.03
  11. Martín E. Fernández-Zapico · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.